Shared on24 Sep 25Fair value Decreased 5.88%
A decline in forecasted revenue growth and a higher future P/E ratio have contributed to analysts lowering Quanex Building Products’ consensus price target from $29.75 to $28.00. What's in the News Class action lawsuit filed alleging Quanex misled investors about significant underinvestment and degraded conditions in Tyman Mexico facility, resulting in unexpected costs and delayed Tyman integration benefits; stock dropped 22% over two trading days following disclosure.
Shared on09 Sep 25Fair value Decreased 12%
The significant downward revision in Quanex Building Products’ price target reflects sharply reduced consensus revenue growth forecasts, with fair value now lowered from $33.75 to $29.75. What's in the News Updated fiscal 2025 earnings guidance with estimated net sales of approximately $1.82 billion.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Increased 1.99%
AnalystConsensusTarget has increased profit margin from 8.4% to 10.7% and decreased future PE multiple from 14.7x to 10.0x.